Search | Proceedings | Concurrent Oral Session Grid | Author Index | eBook

Author Index: J

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Jack, B.
P4-34   DEVELOPING VIRTUAL PATIENT ADVOCATE TECHNOLOGY FOR SHARED DECISION MAKING
Jackson, L.
P2-5   THE COST-EFFECTIVENESS OF SULINDAC-DIFLUOROMETHYLORNITHINE FOR THE PREVENTION OF COLORECTAL CANCER
Jahn, B.
P3-34   VISUALIZING THE OUTCOMES OF DECISION-ANALYTIC MODELING STUDIES IN THE FRAMEWORK OF HEALTH TECHNOLOGY ASSESSMENT,
P4-45   PRELIMINARY OUTCOMES TOWARDS A RISK-BASED MICROSIMULATION DECISION-ANALYTICAL MODEL BASED ON TREATMENT AND COST INPUTS FROM A REAL WORLD COHORT OF BREAST CANCER PATIENTS
Jalal, H.
P1-3   IMPLICATIONS OF USING EFFECTIVENESS INSTEAD OF EFFICACY ON THE COST-EFFECTIVENESS OF BIOLOGICS IN RHEUMATOID ARTHRITIS: A MULTI-STUDY SENSITIVITY ANALYSIS,
P1-4   LINEAR REGRESSION METAMODELING AS A TOOL TO SUMMARIZE AND PRESENT SIMULATION MODEL OUTPUTS,
P1-53   SENSITIVITY ANALYSIS METHODS FOR DECISION MODELS: A REVIEW AND TWO NOVEL TECHNIQUES,
P3-16   WHEN AND FOR WHOM ARE BIOLOGICS COST-EFFECTIVE IN RHEUMATOID ARTHRITIS?
Jansen, J.
A-2   WOMEN'S RESPONSES TO INFORMATION ABOUT OVERDIAGNOSIS IN MAMMOGRAPHY SCREENING
Japa, S.
E-5   A COST-EFFECTIVENESS ANALYSIS OF STATINS FOR PREVENTING CARDIOVASCULAR DISEASE IN PATIENTS WITH CHRONIC KIDNEY DISEASE
Jauregui, B.
P3-45   MODELS USING MODELS: USE OF MICROSIMULATION MODEL RESULTS TO IMPROVE ACCURACY OF AN EXCEL-BASED POLICY ANALYSIS TOOL FOR USE IN THE FIELD
Jenkins, A.
P2-20   MEASURING PREFERENCES AROUND MODES OF DEATH, THE CASE OF IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS
Jenq, G. Y.
P1-36   CHARACTERIZING THE FLOW OF SHORT-STAY PATIENTS IN THE INTENSIVE CARE UNIT
Jiang, Y.
P1-16   WHO INITIATES CANCER SYMPTOM MANAGEMENT DISCUSSIONS? FACTORS ASSOCIATED WITH PATIENT VS. CLINICIAN INITIATION IN WOMEN WITH OVARIAN CANCER
Jit, M.
H-5   AN INTEGRATED APPROACH TO EVALUATING ALTERNATIVE RISK PREDICTION STRATEGIES: A CASE STUDY COMPARING ALTERNATIVE APPROACHES FOR PREVENTING INVASIVE FUNGAL DISEASE
Johnson, A. P.
P2-36   CHOLINESTERASE INHIBITORS: A POPULATION-BASED ASSESSMENT OF RESOURCE UTILIZATION FOR PATIENTS WITH ALZHEIMER'S DEMENTIA
Johnson, M. W.
E-2   COST EFFECTIVENESS OF DIFFERENT INTERVENTIONS FOR TREATING PATIENTS WITH NEWLY-DIAGNOSED DIABETIC MACULAR EDEMA
Johnson, M. G.
P4-38   METHODS FOR EVALUATING STRATEGIES FOR RAPID RESPONSE TEAMS IN HOSPITAL SETTINGS
Johnston, J.
P3-13   IMPACT OF CAREGIVER STATUS ON HEALTH STATE VALUATIONS
Johnston, S. S.
P1-39   PATTERNS AND CORRELATES OF LINKAGE TO APPROPRIATE HIV CARE FOLLOWING HIV DIAGNOSIS IN THE UNITED STATES MEDICAID POPULATION,
P2-8   HEALTHCARE COSTS OF MEDICALLY-ATTENDED ADVERSE EFFECTS IN MEDICAID HIV PATIENTS ON ATAZANAVIR- AND DARUNAVIR-BASED ANTIRETROVIRAL THERAPY
Jonas, D. E.
F-6   USING SIMULATED DATA TO VALIDATE BAYESIAN MIXED TREATMENT COMPARISON META-ANALYSIS FOR DIFFERENT EVIDENCE NETWORK PATTERNS AND NUMBERS OF STUDIES
Jones, C.
P4-28   USING LARGE, RETROSPECTIVE DATASETS TO MAKE COST-EFFECTIVE DECISIONS CONCERNING EMBRYO TRANSFER POLICIES IN FIRST CYCLE IN VITRO FERTILIZATION PATIENTS WHO ARE 38 YEARS OF AGE OR OLDER: A POPULATION-BASED ANALYSIS
Jordan, J.
P3-13   IMPACT OF CAREGIVER STATUS ON HEALTH STATE VALUATIONS
Joy, S.
P2-21   FACTORS IMPACTING STAKEHOLDERS' MOTIVATION FOR IMPLEMENTING NATIONAL LIVER CANCER CONTROL PLANS IN 12 COUNTRIES,
P4-54   ASSESSING THE IMPACT OF ADVOCACY AND PUBLIC AWARENESS ON NATIONAL PRIORITIES FOR LIVER CANCER CONTROL
Juday, T.
P1-39   PATTERNS AND CORRELATES OF LINKAGE TO APPROPRIATE HIV CARE FOLLOWING HIV DIAGNOSIS IN THE UNITED STATES MEDICAID POPULATION,
P2-8   HEALTHCARE COSTS OF MEDICALLY-ATTENDED ADVERSE EFFECTS IN MEDICAID HIV PATIENTS ON ATAZANAVIR- AND DARUNAVIR-BASED ANTIRETROVIRAL THERAPY
Juusola, J. L.
P2-50   HIV TREATMENT AND PREVENTION: A SIMPLE MODEL TO DETERMINE OPTIMAL INVESTMENT
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z